Hims & Hers Health Inc. (NYSE:HIMS) stock is trading lower following a media report revealing that the Federal Trade Commission (FTC) has been investigating the company’s business practices for over a year.
Bloomberg reported Thursday that the Federal Trade Commission has been looking into Hims & Hers Health for over a year, focusing on whether the company makes it too difficult for customers to cancel subscriptions.
